Bayer has high hopes of driving its prostate cancer drug into blockbuster status, meaning over $1 billion in annual sales. This week's ARASENS trial results should help pave the road.
Already approved in non-metastatic castration-resistant prostate cancer, Nubeqa just proved its worth in metastatic hormone-sensitive prostate cancer (mHSPC) too. In the trial, the drug improved overall survival for patients when administered in addition to standard of care, compared to those who received standard of care alone. Increased OS was the primary goal of the trial.
The standard of care in men with mHSPC is a hormone deprivation therapy (ADT) with a strong chemo drug. Nubeqa comes alongside these treatments to attach to the androgen receptor on the prostate cells to block testosterone from connecting to it, thereby delaying cancer growth.
Men with metastatic prostate cancer have a dismal 30% 5-year survival rate. While the specific numbers have not been released, Bayer called the increased over all survival "significant."
Nubeqa is also in a Phase III for men with mHSPC receiving ADT without the chemo. The trial hopes to prove radiological progression-free survival.
Sales numbers haven't been broken down for the Bayer drug since its summer of 2019 approval. The company hopes that's about to change by having the drug entering their top 15 products list. With recent sales falling from two best sellers – stroke prevention pill Xarelto and AMD targeted therapy Eylea – Bayer could use a new blockbuster.
As other big names in life sciences likeJohnson & Johnson, GE and smaller company bluebird bio have decided to split their companies to refocus, Bayer has already determined that's not for them.
"We are going to continue the course, which is developing our company along the three pillars that we have - pharmaceuticals, crop science and consumer health," CEO Werner Baumann told Bloomberg.
The company is paying out big for one of its consumer products. Bayer is facing around 30,000 claims that its glyphosate-containing Roundup caused cancer. An agreement was reached to pay $10 billion to settle the lawsuits already filed. Bayer is seeking to resolve future lawsuits with a settlement fund of up to $2 billion, but that has not yet been approved.
With payouts like these, a big win in the pharma arm is needed. Bayer will look to add approval to market Nubeqa for the additional indication with health authorities worldwide.
Its main competition will be J&J's Erleada, first approved in 2018 and expanded to cover metastatic castration-sensitive prostate cancer, and Pfizer's Xtandi, first approved in 2012 and later developed for additional prostate cancer indications.
Full results of the ARASENS trial will be shared at an "upcoming meeting."
The virus was tested by the Maryland Department of Health's Public Health Laboratory and partners.
Two of the cases stem from the same household, the press release notes, including a vaccinated individual who recently returned from traveling to South Africa and a person in close contact with him or her who was not vaccinated. The third case is not related and the person does not have a notable travel history to trace the contact of the disease.
Hogan's release states that contact tracing is being conducted to quarantine and test people who may have also been exposed.
“Thanks to our aggressive surveillance system, we have quickly identified the first cases of the Omicron variant in Maryland,” Hogan said. “We urge Marylanders to continue taking precautions to keep themselves and their loved ones safe. Getting a vaccine or a booster shot is the single most important thing that you can do to protect yourself and those around you.
"This is a rapidly evolving situation, and we will continue to keep Marylanders updated as new information becomes available," he added.
The omicron variant of COVID-19 has been detected in California, New York, Colorado, Minnesota, Hawaii, Nebraska, and now Maryland, according to Reuters.
According to a person familiar with the matter, the steps laid out would ensure that a modified vaccine for omicron would only take about three months to approve under the reported FDA steps.
White House chief medical adviser Anthony Fauci said Friday, "We could probably get a good bit of mileage just from boosting with the ancestral strain vaccine that we already have."
Sen.Bernie Sanders(I-Vt.) is calling on the Biden administration to delay an increase in Medicare premiums for 2022 that is tied in part to a controversial, pricey Alzheimer's drug.
In a letter sent to President Biden on Friday, Sanders called on him to "prevent the outrageous increase in Medicare Part B premiums associated with the potential approval of the Alzheimer’s drug Aduhelm."
He said the administration should delay Medicare’s approval for use of Aduhelm until it is deemed safe and effective, and take executive action to reinstate and expand the reasonable pricing clause requiring drug makers that receive federal funding to charge reasonable prices for prescription drugs and treatment
Medicare Part B, which covers services like doctors office visits, will increase by $21.60, from $148.50 in 2021 to $170.10 in 2022. Officials said that is one of the largest increases in recent years.
About half of that increase is due to contingency planning to make sure the program has enough money to pay for Aduhelm if Medicare decides to cover it.
The drug, manufactured by Biogen, has drawn controversy both for its price, at $56,000 per year, and because the Food and Drug Administration (FDA) approved it despite doubts from experts about its effectiveness.
Two House committees have launched investigations into the FDA’s decision, and acting FDA Commissioner Janet Woodcock requested a federal probe into the approval process.
Medical centers like the Cleveland Clinic and Mount Sinai Health System declared they would not administer Aduhelm, and the Department of Veterans Affairs and other insurers did not put the drug on their VA National Formulary.
Administration officials emphasized that most people on Medicare will also be getting a large cost of living increase in their Social Security payments next year, which they said would more than offset the rise in Medicare costs for many seniors.
Still, Sanders said it would be "absolutely unacceptable" to force seniors to pay for the cost of a drug that hasn't been scientifically proven to work.
“Biogen’s $56,000 price of Aduhelm is the poster child for how dysfunctional our prescription drug pricing system has become,” Sanders wrote. “The notion that one pharmaceutical company can raise the price of one drug so much that it could negatively impact 57 million senior citizens and the future of Medicare is beyond absurd. With Democrats in control of the White House, the House and the Senate we cannot let that happen.”
Sanders's letter comes as Democrats are trying to bring drug prices under control, but have had to back down from some of the most aggressive tactics proposed for President Biden's Build Back Better plan.
InPresident Biden’s America, “Build Back Better” means cutting spending for hospitals that provide care to underserved communities to fund tax cuts for the super wealthy. It’s quite an example of just how far the Democrats’ socialist agenda has taken them from reality.
What does that mean? As we continue to battle the COVID-19 pandemic, Joe Biden and Nancy Pelosi want to slash federal funds to hospitals who care for low-income patients, along with those who are underserved and uninsured. These patients, who are currently eligible for charitable and low-income assistance, may begin seeing medical bills and incurring medical debt.
It’s worth noting these cuts are not happening in every state. Rather, Biden and Pelosi have targeted states that have opted to not expand Medicaid — Alabama, Florida, Georgia, Kansas, Mississippi, North Carolina, South Carolina, South Dakota, Tennessee, Texas, Wisconsin and Wyoming.
These cuts to DSH and UCP programs will reduce federal funding for providers in 12 states by $34.5 billion over 10 years. Broken down, that’s $4.2 billion in DSH cuts to hospitals in 12 states, and $30 billion in cuts to UCP programs in Texas, Florida, Tennessee and Kansas.
Even worse, all of this appears to have been done in secret. After receiving a letter from Sen. Scott on Nov. 5 warning about the disastrous impacts of these proposed cuts to charity care providers, House Democrats in the 12 impacted states wrote a letter to Nancy Pelosi and Chuck Schumer saying they had not been informed of this addition to the bill. They warned “limiting uncompensated care (UC) pools and cutting disproportionate share hospital (DSH) payments is a misguided penalty that puts our most vulnerable constituents at risk.”
Of course, we’ve seen this partisan, vindictive behavior before. This is just a repeat of Obama administration’s failed health care playbook. Biden and Pelosi have written the bill to punish states that have not adopted their progressive health care agenda. They do this by cutting the availability of care targeted to the poor.
You would think that Democrats — with full control of the House, Senate and the White House — would be doing everything they could to slow rising prices and make life more affordable for American families. And you would think that Democrats would want to partner with their Republican colleagues to focus on legislation that expands opportunity and freedom. Not in a Washington controlled by socialists Sen. Bernie Sanders (I-Vt.) and Rep. Alexandria Ocasio-Cortez (D-N.Y.).
Here is what is clear from Biden and Pelosi’s priorities in this reckless bill: the Democratic Party, terrified of upsetting its elite liberal base, does not care about helping low-income and working-class American families. Biden’s “Build Back Broke” plan adds trillions to the federal deficit, which will only further fuel his raging inflation crisis that just last month hit the highest levels seen in more than 30 years. The plan also includes massive SALT tax breaks for Democrats’ rich blue-state donors while raising taxes on working, middle class Americans. In today’s Democratic Party, it’s socialism over everything, even when that means hurting families and small businesses with more taxes, more regulation and more inflation. We completely oppose it and the radical agenda the Democrats in Washington have adopted as their new religion.
The disastrous cuts to charity care providers that Pelosi and Biden are pushing are just what we’ve come to expect in Democrat-controlled Washington. Cutting this care to help pay for tax cuts for the rich makes no sense and can’t be allowed to pass. But that doesn’t mean we aren’t going to fight like hell to stop this and we hope at least some of our colleagues on the other side of the aisle will join us.
For Democrats, the question is simple: are you willing to cut services and hurt families in your own state to appease Pelosi and conform with her tyrannical House? The answer should be easy: “No.” We’ll keep fighting for the families of our states and urge others in Washington to have the courage to do the same.
Rick Scott is the junior senator from Florida and Ted Cruz is the junior senator from Texas.
While scientists continue to determine just how deadly, and how transmissible the new Omicron Covid strain is, it's worth noting that South Africa has seen its new daily COVID cases quadruple in recent days, even if the vast majority of these new vases have only mild symptoms.
Whether it's omicron or some kind of seasonal dynamic driving it, South Africa’s daily number of confirmed COVID cases almost quadrupled from Tuesday as the omicron variant spread across the country. The country recorded 16,055 infections in the last 24 hours and a positivity rate accelerated to 24.3% from 16.5% on Tuesday, according to the National Institute for Communicable Diseases.
A South African study of infections since the start of the pandemic found that the risk of reinfection from the omicron coronavirus variant is three times higher than for any previous strain.
Back in North America, the number of confirmed omicron cases in Canada has risen to 11.
A South African study of infections since the start of the pandemic found that the risk of reinfection from omicron is three times higher than for any previous strain.
Another 25 COVID deaths were reported in South Africa, bringing total fatalities to 89,944 to date. Hospitals reported an increase of 279 admissions in the past 24 hours, bringing the total to 3,202. In Gauteng each infected person on average is able to pass on the virus to another 2.33, according to the National Institute for Communicable Diseases. That’s a record rate, and any level over 1 means the virus’s spread is accelerating.
It's not just Pfizer that's scrambling to get a head start on its research into the omicron variants; the WHO said Friday that some 450 researchers from around the world are teaming up to isolate the highly mutated COVID strain, grow it in a slab, validate its genomic sequences.
The new strain's rapid spread across South Africa has raised concerns that the omicron variant can more easily surpass vaccine protections.
"We welcome that because they will help us to prepare," she said. "WHO is contacting each of the vaccine manufacturers and requesting from them information on their current plans to modify their vaccines, if they have any preliminary data, and the time line for the scaling up and implementation of the modifications." -Bloomberg
As American authorities search for more cases of omicron, Bloomberg reported that NYC has a new problem: informing all 53K attendees of a recent anime convention at the Javits Center that they should strongly consider getting tested.
Omicron cases have been found in at least half a dozen states. Five cases have been found in New York State. One was found in California, another in Minnesota (after returning from NYC). And cases have been found in Hawaii, Nebraska and Colorado.
Finally, the President of Botswana told CNN in an interview that four diplomats who visited his country earlier in November were actually the first individuals to be carrying the omicron variant. President Mokgweetsi Masisi said some of the diplomats included Europeans. Botswana is home to the first case of omicron.
1). PetVivo Holdings, Inc. (NASDAQ:PETV) 2). Cryptocurrency – BEEMUPs (CRYPTO: YOM ($YOM) 3). Gaensel Energy Group, Inc. (OTCPINK: GEGR) 4). Epazz, Inc. (OTCPINK: EPAZ) 5). GlobeX Data Ltd. (OTCQB: SWISF) (CSE: SWIS) (FRA: GDT) 6). Rego Payments Architectures, Inc. (OTCQB: RPMT) 7). Starfleet Innotech, Inc. (OTCPINK: SFIO) (a.k.a-Smokefree Innotec, Inc.)8). Sekur® (a division of GlobeX Data, Ltd) “SPECIAL SEGMENT – Weekly Hack”
1). PetVivo Holdings, Inc. (NASDAQ:PETV) 2). Cryptocurrency – BEEMUPs (CRYPTO: YOM ($YOM) 3). Gaensel Energy Group, Inc. (OTCPINK: GEGR) 4). Epazz, Inc. (OTCPINK: EPAZ) 5). GlobeX Data Ltd. (OTCQB: SWISF) (CSE: SWIS) (FRA: GDT) 6). Rego Payments Architectures, Inc. (OTCQB: RPMT) 7). Starfleet Innotech, Inc. (OTCPINK: SFIO) (a.k.a-Smokefree Innotec, Inc.)8). Sekur® (a division of GlobeX Data, Ltd) “SPECIAL SEGMENT – Weekly Hack”
FMW Media’s New To The Street / Newsmax TV announces the broadcasting line-up of its national syndicated TV show this Sunday, December 5, 2021, airing 10-11 AM ET.
New to The Street’s 271st TV show line-up, features eight (8) interviews of the following Companies and their businesses representatives:
4). Epazz, Inc.’s (OTCPINK: EPAZ) interview, Mr. Michael Manahan, Vice-president Communications.
5). GlobeX Data Ltd.’s (OTCQB: SWISF) (CSE: SWIS) (FRA: GDT) interview, Mr. Alain Ghiai, CEO.
6). Rego Payments Architectures, Inc.’s. (OTCQB: RPMT) interviews, Mr. Dan Aptor, Head of Strategy/Marketing, and Ms. Annie Douglas, Executive Vice-president, May Media Group.
Mr. John Lai, CEO & President, PetVivo Holdings, Inc. (NASDAQ:PETV), arrives in-studio at NASDAQ, talking with New to The Street TV’s Anchor Jane King, about the Company’s biomedical devices, in particular, the osteoarthritis treatment available to millions of dogs and horses. He talks about the most recent financial results and that the Company continues to spend money on hiring talented people. The media campaign, which includes digital billboard streaming in New York City, gives PETV another avenue to advertise the Company’s ongoings. John explains the rebranding of Kush into its new name, Spring. As a one-time treatment delivered by your veterinarian, Spryng™ with OsteoCushion™ Technology is an injection that can show positive results for approximately 12 months or longer for the treatment of osteoarthritis. John tells viewers about upcoming trade shows in Nashville and Orlando. Cat pet owners can expect some time in 2022, an osteoarthritis treatment designed to improve feline joint function.
New to the Street TV welcomes Mr. Alex van der Bann, CEO/Co-Founder, BEEMUP(CRYPTO: YOM) ($YOM), for his NASDAQ in-studio interview with Anchor Jane King. Alex provides information about the evolution of the metaverse and how that evolution involves BEEMUP. Young and old become more involved in the metaverse, and BEEMUP links virtual experiences with its NFT, $YOM (Your Open Metaverse) utility token. Individuals and corporations can create a metaspace virtual branding of goods and services. Since the innovation of the blockchain and the launch of Bitcoin in 2009, exponentially, DeFi transactions remain extraordinary. Alex explains the need for more reliability and transparency in the NFT space, paramount for further acceptance in the tokenization of assets and the transfer of those tokens’ values. BEEMUP’s $YOM token provides a unique marriage of the metaverse and NFT, using its reliable platform to create exclusive trades, perks, abilities, and rewards. BEEMUP gives a creative outlet for virtual brand identity and launches “BEEMUP” into the metaverse.
Mr. Michael Clebnik, Chief Financial Officer/Co-Founder at Metro VR Studios, a Gaensel Energy Group, Inc. (OTCPINK:GEGR) subsidiary, joins New to the Street TV Anchor Jane King for a NASDAQ in-studio interview. Mr. Clebnik talks about GEGR’s VR (Virtual Reality) business, along with his years of international business acumen in technology-based companies. Michael explains the business expectations ahead at subsidiary Metro VR Studios, a VR (Virtual Reality) development Company that focuses on developing high-quality, character-driven action and games for VR on Oculus, SteamVR, and PSVR. With Metaverse’s (Facebook) launch of Quest 2, the whole VR content platform changed, and as such, content is a must, not just for games but for other industries, including music videos. Peter explains how Metro VR’s new software works with VR headsets.
Mr. Mike Manahan, Vice-president Communications at Epazz, Inc. (OTCPINK: EPAZ), arrives on-set at NASDAQ on this week’s New to The Street TV Talking with TV Anchor Jane King, viewers learn from Mike about the Company’s software blockchain cloud products which the Company sells to fortune 500 companies, large and small businesses, governmental offices, and educational entities. Mr. Manahan explains Epazz’s intranet software solutions, customized for a wide variety of organizations and companies. He gives three examples of software applications that the Company offers to end-users, ZenaPay Wallet, Epazz StreamPay, and Epazz CryObo Blockchain Technology. Mike explains how the real-estate industry, supply-chain management, and cannabis producers/suppliers utilize these solutions. Because the Company continues to evolve legacy software platforms into more efficient blockchain digital solutions, Mr. Manahan explains that value proposition to investors.
Mr. Alain Ghiai, CEO at GlobeX Data Ltd. (OTCQB: SWISF) (CSE: SWIS) (FRA: GDT), talks to New to Street TV Anchor Jane King about the Company’s Sekur® solutions to prevent hacks from emails and text messages. This week, Alain provides insight into the growth of ransomware attacks and the overall problem costing world economies billions of dollars. Based on a US Treasury report, during the first ½ of 2021, the attacks exceeded all ransom payouts in the last decade. Alain explains the direct and indirect cost from such hacks and cybersecurity ransoms looks to be around $6T worldwide. The ransomware hackers look to take down more high-profile targets like power plants. The cybersecurity industry needs to ramp up counter-offensives to protect critical industries that appear vulnerable. GlobeX Data Ltd.’s Sekur®, with its proprietary HeliX technology and other encryption solutions, can eliminate hacks. With no request for phone numbers, no open-source platform, no Microsoft Office 360, no shared servers, never selling or mining data, GlobeX Data Ltd. can offer cybersecurity solutions for a monthly fee. As an added protection to subscribers, GlobeX Data Ltd. operates its internet platforms and security businesses under the country of Switzerland’s very tough privacy laws.
New to The Street TV airs Anchor Jane King’s interviews with Mr. Dan Aptor, Head of Strategy and Marketing at Rego Payment Architectures, Inc. (OTCQB:RPMT) (“REGO”), and Ms. Annie Douglas, Executive Vice-president, May Media Group. Mr. Aptor explains the Company’s neo-bank and privacy-first fintech platform for commercial and individual online and in-store wallet applications. With over 70 million Generation ‘Z’ (GenZ) children now fully participating in digital commerce, Dan explains the Company’s Mazoola super digital wallet app. REGO’s Mazoola wallet continues as COPPA (Children’s Online Privacy Protection Act) and EU GDPR (General Data Protection Regulation) compliant product and service. Because of built-in protections that focus on children’s well-being and identities, the Company received a prestigious award from the National Parenting Product Awards (NAPPA). Dan reminds viewers about its 3 patents and that the Mazoola wallet never collects, stores, or sells data, and parental controls remain in place to limit monetary exposures and manage children’s use. Ms. Annie Douglas talks about her organization and her affiliation with “Moms Meet.” As a large community, “Moms Meet” offers mothers looking to learn more about “better-for-you” products and services and then interact with one another, providing feedback on tried products. She explains that Mom Meets went into a partnership with Rego’s Mazoola wallet because of the child privacy-first technology platform and all its security features. REGO’s unique platform makes it fun, learns and teaches children financial literacy, and contains an encrypted digital footprint, a must in today’s fintech space. Viewers can download the Mazoola super digital wallet app “FREE” for 12 months - https://mazoola.co/
Mr. Richard Proigalidad, CEO/ President at Leentech Network Solutions, a Starfleet Innotech, Inc. (a.k.a-Smokefree Innotec, Inc.) (OTCPINK:SFIO) subsidiary, appears on this week’s New to The Street TV show talking with TV Anchor Jane King. Mr. Proigalidad discussed the pending corporate action with OTC Markets on removing SFIO’s “Shell” status designation and all necessary documentation provided for review. He then discusses the technology and software division at SFIO and how that division works within the verticals at SFIO. The Leentech Network Solution team develops and collaborates a technological business platform for small to medium-sized businesses, using AI and data analytics to formulate a digital recommendation to help increase productivity and efficiencies. Mr. Proigalidad explains how this modeling improved SFIO’s subsidiary Gorgeous Coffee Company and its global distribution and license to the Epiphany coffee blend brand.
The “WEEKLY HACK - SPECIAL SEGMENT” with internationally acclaimed internet privacy expert Mr. Alain Ghiai, CEO, Sekur®, a division of GlobeX Data, Ltd. New to The Street TV. Host Ana Berry and Alain talk about cybersecurity hacks that become common attacks during the holiday season. Alain explains that the electronic gift card app remains a choice digital scam by the “Dark Web.” Recent digital gift card hacks enabled malware onto mobile devices, which revealed all the contents of text messenger apps. As such, the hackers found data about crypto wallet apps and helped them steal Bitcoin and other altcoins in crypto wallets. Alain calls it “Crypto Jacks” and warns everyone “NOT” to open a text and email from an unlikely source; it could cause a hack of your data. A solution for year-round protection, get the Sekur® email and messenger for only $10.00 per month. The Sekur product lines provide end-users with private texting and email for both the sender and the receiver, protecting those not subscribers to Sekur. Always, Alain reminds everyone about password protections and other cybersecurity diligence needed, especially during the holiday season. What is your privacy worth this HOLIDAY SEASON?”
About PetVivo Holdings, Inc. (NASDAQ:PETV):
PetVivo, Inc. (NASDAQ:PETV), based in Minneapolis, Minnesota, is an emerging biomedical device company focused on licensing and commercializing innovative medical devices for pets or pet therapeutics. PetVivo believes that it can leverage the investments in the human bio-materials and medical device industries to commercialize therapeutics to pets in a capital and time-efficient ways. PetVivo’s strategy is to in-license proprietary products from human medical device companies specifically for use in pets. A key component of this strategy is the accelerated timeline to revenues for veterinary medical devices, which enter the market much earlier than the more stringently regulated pharmaceuticals - https://petvivo.com/.
BEEMUP, with its utility token YOM (Your Open Metaverse), enables artists, developers, and businesses to co-create an open metaverse content that belongs to you. Visit live performances in dynamic virtual worlds with your friends and collect exclusive branded wearables. Create your metaspaces and experiences in Unreal Engine and publish these live to any website or channel. Mint your 3D assets as NFTs and airdrop them in your metaspace as part of a virtual auction or giveaway - https://beemup.com/ and https://www.yom.community/
About Gaensel Energy Group, Inc. (OTCPINK: GEGR):
Gaensel Energy Group, Inc. (OTCPINK:GEGR) is an international finance and holding company that combines its management team’s cumulative and collective knowledge. The Company’s management team consists of experienced and successful professionals in Europe, Asia, North and Latin America. As GEGR expands rapidly through a series of fifteen highly diversified acquisitions or investments, it currently consists of various industries, including Biotech, Commodities, Apparel, Fashion, Green and Renewable Energy, and Technology. The Company’s revenues and earnings have grown considerably because of these acquisitions. GEGR has the accounting, legal, and management organization with structural skill sets to effectively evaluate and make prompt business decisions and the resource network to facilitate high-level transactions - https://gegrgroup.com/.
About Epazz, Inc. (OTCPINK: EPAZ):
Epazz, Inc. (OTCPINK: EPAZ) is a leading cloud-based software Company that provides customized cloud applications to the corporate world, higher-education institutions, and the public sector. Epazz BoxesOS v3.0 is the complete business web-based software package for small to midsize businesses, Fortune 500 enterprises, government agencies, and higher education institutions. BoxesOS provides a combination of many web-based applications that an organization would otherwise need to purchase separately. Epazz’s other products are DeskFlex (room scheduling software) and Provitrac (applicant-tracking system) - https://www.epazz.com/.
About GlobeX Data Ltd. (OTCQB:SWISF) (CSE:SWIS) (FRA:GDT):
GlobeX Data Ltd. (OTCQB:SWISF) (CSE:SWIS) (FRA:GDT) is a Cybersecurity and Internet Privacy provider of Swiss hosted solutions for secure communications and secure data management. The Company distributes a suite of secure messaging applications, encrypted emails, secure communications, and secure data management tools, using Swiss privacy laws, proprietary technology, and its independent platform, away from big techs hosting platforms. GlobeX Data Ltd. sells its products through approved wholesalers, distributors, and telecommunications companies worldwide. GlobeX Data Ltd. serves consumers, businesses, and governments worldwide – https://www.globexdata.com. Sekur® is a Swiss secure communications application offering secure and private messaging, emails, voice messages, self-deleting messages, and file transfers from any mobile device, tablet, or desktop. Sekur users can communicate with Sekur and non-Sekur users through its unique Chat-By-Invites feature and Sekur, send email system. All data traffic stays in GlobeX Data’s Swiss-hosted servers, using its proprietary HeliX technology, military-grade encryption, and benefiting from Swiss Privacy Laws – https://sekur.com. Twitter: @globexdata.
About REGO Payment Architectures, Inc. (OTCQB: RPMT):
REGO Payment Architectures, Inc. (OTCQB:RPMT) (“REGO”) is a digital solution that enables children to stay safe in today’s tech-first environment. The REGO Digital Wallet platform, MazoolaSM, allows parents and guardians to allow online shopping or digital spending at approved retailers, control what funds are available for which purchases, and reward children or pay allowance via the app. REGO is an innovative financial platform uniquely positioned due to its Children’s Online Privacy Protection Act (COPPA) and General Data Protection Regulation (GDPR) compliance- www.regopayments.com.
About Starfleet Innotech, Inc. (OTCPINK:SFIO)
Starfleet Innotech, Inc. (OTCPINK:SFIO) (a.k.a. Smokefree Innotec, Inc.) is an asset management company focused on innovation through disruptive collaborations across its three key industries: Food and Beverage (F&B), Real Estate, and Technology. With a strong presence across New Zealand, Australia, and the Philippines, as well as a roadmap for further global expansion, SFIO makes strategic investments in high-growth businesses, building synergies across its diverse portfolio to provide maximum shareholder value. Guided by tradition, driven by innovation, and enabled by collaboration - SFIO is on a hyper-growth path to building a thriving business ecosystem, with plans to up-list onto a major stock exchange in the future - https://sfio.co.nz/.
French medical device company Carmat on Friday said it had suspended implants of its Aeson artificial hearts following a quality issue affecting some of its prostheses.
Given recurring shortages of donors, Carmat's device aims to give patients with end-stage biventricular heart failure, a deadly condition where the heart is no longer able to pump blood adequately around the body, an alternative to hospital stays.
Earlier this year, it launched commercially in the European Union after receiving European Commission approval and launched a feasibility study in the United States.
